Results 191 to 200 of about 4,213 (269)

Certolizumab pegol for plaque psoriasis in women of childbearing potential, pregnant or breastfeeding in clinical settings: One‐year outcomes from the international noninterventional CIMREAL study

open access: yes
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Tom Hillary   +11 more
wiley   +1 more source

Therapeutic hypothermia success for hypoxic‐ischaemic encephalopathy in Latin America: Eight‐year experience in EpicLatino Neonatal Network

open access: yesActa Paediatrica, Volume 114, Issue 5, Page 922-928, May 2025.
Abstract Aim A study reported that therapeutic hypothermia (TH) did not reduce the combined prognosis of mortality and disability at 18 months, in low‐ and middle‐income countries for patients with hypoxic ischaemic encephalopathy (HIE) who received TH, suggesting its no implementation in these regions.
Carlos Fajardo   +7 more
wiley   +1 more source

Fc-empowered exosomes with superior epithelial layer transmission and lung distribution ability for pulmonary vaccination

open access: yesBioactive Materials
Mucosal vaccines offer potential benefits over parenteral vaccines for they can trigger both systemic immune protection and immune responses at the predominant sites of pathogen infection.
Fan Meng   +11 more
doaj  

Protective immune response against Rhodococcus equi: An innate immunity‐focused review

open access: yesEquine Veterinary Journal, Volume 57, Issue 3, Page 563-586, May 2025.
Abstract Rhodococcus equi causes pyogranulomatous pneumonia in foals and immunocompromised people. Despite decades of research efforts, no vaccine is available against this common cause of disease and death in foals. The purpose of this narrative review is to summarise the current understanding of interactions between R. equi and the host innate immune
Bibiana Petri da Silveira   +4 more
wiley   +1 more source

Maternal IgE Influence on Fetal and Infant Health

open access: yesImmunological Reviews, Volume 331, Issue 1, May 2025.
ABSTRACT Immunoglobulin E (IgE) is the most recently discovered and evolved mammalian antibody type, best known for interacting with mast cells (MCs) as immune effectors. IgE‐mediated antigen sensing by MC provides protection from parasites, venomous animals, bacteria, and other insults to barrier tissues exposed to the environment.
Jozef Balla   +2 more
wiley   +1 more source

European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: Treatment

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 39, Issue 5, Page 899-941, May 2025.
HS treatment algorithm. Abstract Introduction This second part of the S2k guidelines is an update of the 2015 S1 European guidelines. Objective These guidelines aim to provide an accepted decision aid for the selection, implementation and assessment of appropriate and sufficient therapy for patients with hidradenitis suppurativa/acne inversa (HS ...
C. C. Zouboulis   +36 more
wiley   +1 more source

Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases

open access: yesAdvanced Science, Volume 12, Issue 13, April 3, 2025.
This article reviews the use of fecal microbiota transplantation (FMT) to treat intestinal diseases like recurrent Clostridioides difficile infection (rCDI), inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS). It discusses FMT's efficacy, influencing factors such as donor selection, recipient characteristics, and treatment protocols ...
Shuna Hou   +4 more
wiley   +1 more source

Congenital Titinopathy: Comprehensive Characterization of the Most Severe End of the Disease Spectrum

open access: yesAnnals of Neurology, Volume 97, Issue 4, Page 611-628, April 2025.
Congenital titinopathy has recently emerged as one of the most common congenital muscle disorders. Objective To better understand the presentation and clinical needs of the under‐characterized extreme end of the congenital titinopathy severity spectrum.
Sandra Coppens   +71 more
wiley   +1 more source

Home - About - Disclaimer - Privacy